Jagsonpal Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 554.51 million compared to INR 512.27 million a year ago. Revenue was INR 580.1 million compared to INR 515.93 million a year ago. Net income was INR 56.03 million compared to INR 3.15 million a year ago. Basic earnings per share from continuing operations was INR 2.14 compared to INR 0.12 a year ago. Diluted earnings per share from continuing operations was INR 2.14 compared to INR 0.12 a year ago.
For the full year, sales was INR 2,367.14 million compared to INR 2,175.84 million a year ago. Revenue was INR 2,424.48 million compared to INR 2,210.11 million a year ago. Net income was INR 267.21 million compared to INR 188.56 million a year ago. Basic earnings per share from continuing operations was INR 10.2 compared to INR 7.2 a year ago. Diluted earnings per share from continuing operations was INR 10.2 compared to INR 7.2 a year ago.